共 22 条
[1]
Liver (ICD-O 155), TNM classification of malignant tumours, pp. 53-55, (1982)
[2]
Berke G., Functions and mechanisms of lysis induced by cytotoxic T lymphocytes and natural killer cells, Fundamental immunology, pp. 735-764, (1989)
[3]
Berman C., Primary carcinoma of the liver, Adv Cancer Res, 5, pp. 55-96, (1958)
[4]
Sakamoto M., Hirohashi S., Tsuda H., Shimosato Y., Makuuchi M., Hosoda Y., Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern, Am J Surg Pathol, 13, pp. 1064-1067, (1989)
[5]
Arakawa M., Kage M., Sugihara S., Nakashima T., Suenaga M., Okuda K., Emergence of malignant lesions within an adenomatous hyperplastic nodule in cirrhotic liver, Gastroenterology, 91, pp. 198-208, (1986)
[6]
Yamamoto Y., Iizuka H., Yamamoto M., Tasaka K., Sugahara K., A proposal of effective immunochemotherapy using recombinant interleukin 2 and Adriamycin, and its theoretical background, Yamanashi Med J, 5, pp. 25-34, (1990)
[7]
Whiteside T., Herberman R.B., The role of natural killer cells in human disease, Clin Immunol Immunopathol, 53, pp. 1-23, (1989)
[8]
The general rules for the clinical and pathological study of primary liver cancer, Jpn J Surg, 19, pp. 98-129, (1989)
[9]
Talmadge J.E., Herberman R.B., Cancer Treat Rep, 70, pp. 171-182, (1986)
[10]
Rosenberg S.A., Lotze M.T., Muul L.M., Chang A.E., Avis F.P., Leitman S., Linehan W.M., Robertson C.N., Lee R.E., Rubin J.T., Seipp C.A., Simpson C.G., White, A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activited killer cells and Interleukin-2 or high dose IL2 alone, N Engl J Med, 316, pp. 889-897, (1987)